AL
ACN icon

Aspiriant LLC’s Accenture ACN Stock Holding History

Aspiriant LLC’s Portfolio ACN Stock Details ACN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,247
Closed -$247K – 402
2026
Q1 		$247K Buy
1,247
+120
+11% +$28K 0.01% 311
2025
Q4 		$302K Buy
1,127
+280
+33% +$71.1K 0.01% 279
2025
Q3 		$209K Sell
847
-2,319
-73% -$605K 0.01% 293
2025
Q2 		$946K Buy
3,166
+230
+8% +$70K 0.03% 151
2025
Q1 		$916K Sell
2,936
-58
-2% -$20.5K 0.03% 144
2024
Q4 		$1.05M Buy
2,994
+143
+5% +$51.5K 0.04% 139
2024
Q3 		$1.01M Sell
2,851
-42
-1% -$13.8K 0.04% 143
2024
Q2 		$878K Sell
2,893
-1,035
-26% -$317K 0.04% 148
2024
Q1 		$1.36M Buy
3,928
+809
+26% +$295K 0.06% 125
2023
Q4 		$1.09M Sell
3,119
-166
-5% -$53.5K 0.05% 140
2023
Q3 		$1.01M Buy
3,285
+167
+5% +$52.6K 0.05% 134
2023
Q2 		$962K Buy
3,118
+140
+5% +$40.7K 0.05% 138
2023
Q1 		$851K Buy
2,978
+69
+2% +$18.8K 0.04% 144
2022
Q4 		$776K Sell
2,909
-33
-1% -$9.13K 0.04% 146
2022
Q3 		$757K Buy
2,942
+1
+0% +$289 0.04% 141
2022
Q2 		$816K Sell
2,941
-15
-0.5% -$4.51K 0.04% 134
2022
Q1 		$996K Sell
2,956
-270
-8% -$91.1K 0.05% 131
2021
Q4 		$1.34M Buy
3,226
+1,072
+50% +$391K 0.07% 115
2021
Q3 		$689K Sell
2,154
-2
-0.1% -$651 0.04% 140
2021
Q2 		$637K Buy
2,156
+12
+0.6% +$3.44K 0.04% 143
2021
Q1 		$593K Buy
2,144
+61
+3% +$15.8K 0.04% 135
2020
Q4 		$543K Buy
2,083
+20
+1% +$4.79K 0.04% 141
2020
Q3 		$466K Sell
2,063
-1
-0% -$229 0.04% 154
2020
Q2 		$443K Sell
2,064
-62
-3% -$11.7K 0.04% 134
2020
Q1 		$348K Buy
2,126
+72
+4% +$13.9K 0.03% 145
2019
Q4 		$432K Sell
2,054
-45
-2% -$8.77K 0.04% 150
2019
Q3 		$404K Sell
2,099
-15
-0.7% -$2.9K 0.04% 161
2019
Q2 		$391K Hold
2,114
– – 0.03% 165
2019
Q1 		$373K Sell
2,114
-89
-4% -$14K 0.03% 166
2018
Q4 		$311K Buy
2,203
+119
+6% +$18.8K 0.02% 181
2018
Q3 		$354K Sell
2,084
-470
-18% -$78.2K 0.03% 181
2018
Q2 		$418K Buy
2,554
+403
+19% +$62.7K 0.04% 176
2018
Q1 		$330K Buy
+2,151
New +$341K 0.03% 184
2017
Q4 		– Sell
-2,204
Closed -$298K – 84
2017
Q3 		$298K Buy
2,204
+121
+6% +$15.8K 0.03% 166
2017
Q2 		$258K Sell
2,083
-8
-0.4% -$975 0.02% 185
2017
Q1 		$251K Buy
2,091
+62
+3% +$7.4K 0.02% 185
2016
Q4 		$238K Hold
2,029
– – 0.02% 173
2016
Q3 		$248K Sell
2,029
-95
-4% -$10.8K 0.02% 171
2016
Q2 		$241K Buy
2,124
+95
+5% +$11K 0.02% 168
2016
Q1 		$234K Buy
2,029
+500
+33% +$51.4K 0.02% 159
2015
Q4 		$207K Buy
+1,529
New +$161K 0.02% 76
2015
Q3 		– Sell
-2,082
Closed -$201K – 106
2015
Q2 		$201K Sell
2,082
-247
-11% -$23.6K 0.02% 111
2015
Q1 		$218K Hold
2,329
– – 0.03% 82
2014
Q4 		$208K Buy
+2,329
New +$193K 0.03% 86

Other funds holding ACN

GA
Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
PTC
Provident Trust Company Waukesha, Wisconsin $4.77B AUM 29.31% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aspiriant LLC's ACN Position: Q2 2026 in Review

Aspiriant LLC sold out of Accenture (ACN) in Q2 2026, closing a stake of 1,247 shares — an estimated $247K sold.

Aspiriant LLC first reported a position in ACN in Q4 2014 and held it in 44 quarters. The position peaked at $1.36M in Q1 2024. 731 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

  • Aspiriant LLC reported no remaining Accenture position as of Q2 2026 after selling out during the quarter.
  • Aspiriant LLC sold 1,247 Accenture shares in Q2 2026, an estimated $247K.
  • Aspiriant LLC first reported a position in Accenture in Q4 2014 and held it in 44 quarters.
  • Aspiriant LLC's Accenture position peaked at $1.36M in Q1 2024.
  • 731 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.